Abstract:Abstract Background Cervical cancer (CC) is the leading cause of cancer-related death in women. A limited number of studies have investigated whether immune-prognostic features can be used to predict the prognosis of CC. This study aimed to develop an improved prognostic risk scoring model (PRSM) for CC based on immune-related genes (IRGs) to predict survival and determine the key prognostic IRGs. Methods We downloaded the gene expression profiles and clinical data of CC patients from the TCGA and GEO databases. The ESTIMATE algorithm was used to calculate the score for both immune and stromal cells. Differentially expressed genes (DEGs) in different subpopulations were analyzed by “Limma”. A weighted gene co-expression network analysis (WGCNA) was used to establish a DEG co-expression module related to the immune score. Immune-related gene pairs (IRGPs) were constructed, and univariate- and Lasso-Cox regression analyses were used to analyze prognosis and establish a PRSM. A log-rank test was used to verify the accuracy and consistency of the scoring model. Identification of the predicted key IRG was ensured by the application of functional enrichment, DisNor, protein–protein interactions (PPIs) and heatmap. Finally, we extracted the key prognostic immune-related genes from the gene expression data, validated the key genes by immunohistochemistry and analyzed the correlation between their expression and drug sensitivity. Results A new PRSM was developed based on 22 IRGPs. The prognosis of the low-risk group in the model group ( P < 0.001) and validation group ( P = 0.039) was significantly better than that in the high-risk group. Furthermore, M1 and M2 macrophages were highly expressed in the low-risk group. Retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs) and the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway were significantly enriched in the low-risk group. Three representative genes (CD80, CD28, and LCP2) were markers of CC prognosis. CD80 and CD28 may more prominent represent important indicators to improve patient prognosis. These key genes was positively correlated with drug sensitivity. Finally, we found that differences in the sensitivity to JNK inhibitors could be distinguished based on the use and risk grouping of this PRSM. Conclusions The prognostic model based on the IRGs and key genes have potential clinical significance for predicting the prognosis of CC patients, providing a foundation for clinical prognosis judgment and individualized treatment.

Identification of Two Novel Genes SNX10 and PTGDS with Cervical Squamous Cell Carcinoma Prognosis

Prognostic Value of Two Novel Genes SNX10 and PTGDS for Cervical Squamous Cell Carcinoma: an Integrated Bioinformatic Analysis

SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.

Identification Oftyrobpandc1qbas Two Novel Key Genes with Prognostic Value in Gastric Cancer by Network Analysis

Identification of 10 differentially expressed genes involved in the tumorigenesis of cervical cancer via next-generation sequencing

Identification of EPHX2 and RMI2 As Two Novel Key Genes in Cervical Squamous Cell Carcinoma by an Integrated Bioinformatic Analysis

Comprehensive analysis reveals novel gene signature in head and neck squamous cell carcinoma: predicting is associated with poor prognosis in patients

Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets

Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis

Identification of Novel Hub Genes Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma by Completive Bioinformatics Analysis

Identification of Novel Subtypes Based on Ssgsea in Immune‐related Prognostic Signature for Tongue Squamous Cell Carcinoma

Identification of key genes associated with cervical cancer based on bioinformatics analysis

Comprehensive analysis of prognostic immune-related genes and drug sensitivity in cervical cancer

Methylation-driven Genes and Their Prognostic Value in Cervical Squamous Cell Carcinoma.

Identification of prognosis-related genes in the cervical cancer immune microenvironment

A 10-gene prognostic methylation signature for stage I–III cervical cancer

Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.

Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis.